Brooks Gabriel, Chief Medical Officer of Solid Biosciences Inc. ($SLDB), sold shares on the open market four times over the last year for a total of nearly $281,000. His most recent sale occurred on February 18, 2026. Among 11,678 insiders with open market sales, his activity ranks 7,696th, well below the average of $8.6 million and 6.4 transactions per seller. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 18, 2026 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | S | Common Stock | 0 | $5.82 | 89,466.0000 | 94,417,746 | 0.00% | 0.00% |
| Feb. 13, 2026 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | M | Common Stock | 10937 | $0.00 | 95,029.0000 | 94,417,746 | 13.01% | 0.01% |
| Feb. 13, 2026 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | M | Restricted Stock Units | 10937 | $0.00 | 21,876.0000 | 94,417,746 | 33.33% | 0.01% |
| Feb. 4, 2026 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | S | Common Stock | 12616 | $6.44 | 84,092.0000 | 94,417,746 | 13.05% | 0.01% |
| Jan. 29, 2026 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | A | Employee Stock Option (Right to Buy) | 207450 | $0.00 | 207,450.0000 | 94,417,746 | 9999.99% | 0.22% |
| Jan. 29, 2026 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | M | Performance Stock Units | 58847 | $0.00 | 0.0000 | 94,417,746 | 100.00% | 0.06% |
| Feb. 2, 2026 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | S | Common Stock | 28335 | $6.44 | 96,708.0000 | 94,417,746 | 22.66% | 0.03% |
| Jan. 31, 2026 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | M | Common Stock | 28225 | $0.00 | 125,043.0000 | 94,417,746 | 29.15% | 0.03% |
| Jan. 29, 2026 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | M | Common Stock | 58847 | $0.00 | 96,818.0000 | 94,417,746 | 154.98% | 0.06% |
| Jan. 31, 2026 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | M | Restricted Stock Units | 28225 | $0.00 | 84,675.0000 | 94,417,746 | 25.00% | 0.03% |
| Jan. 29, 2026 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | A | Restricted Stock Units | 103750 | $0.00 | 103,750.0000 | 94,417,746 | 9999.99% | 0.11% |
| Oct. 20, 2025 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | S | Common Stock | 2895 | $5.96 | 33,819.0000 | 94,417,746 | 7.89% | 0.00% |
| Oct. 18, 2025 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | M | Common Stock | 9750 | $0.00 | 36,714.0000 | 94,417,746 | 36.16% | 0.01% |
| Oct. 18, 2025 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | M | Restricted Stock Units | 9750 | $0.00 | 19,500.0000 | 94,417,746 | 33.33% | 0.01% |
| Aug. 14, 2025 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | A | Employee Stock Option (Right to Buy) | 142500 | $0.00 | 142,500.0000 | 40,816,694 | 9999.99% | 0.35% |
| Aug. 14, 2025 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | A | Restricted Stock Units | 71250 | $0.00 | 71,250.0000 | 40,816,694 | 9999.99% | 0.17% |
| Feb. 13, 2025 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | M | Restricted Stock Units | 10937 | $0.00 | 32,813.0000 | 40,816,694 | 25.00% | 0.03% |
| Feb. 14, 2025 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | S | Common Stock | 3256 | $3.96 | 22,812.0000 | 40,816,694 | 12.49% | 0.01% |
| Feb. 13, 2025 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | M | Common Stock | 10937 | $0.00 | 26,068.0000 | 40,816,694 | 72.28% | 0.03% |
| Jan. 31, 2025 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | A | Restricted Stock Units | 112900 | $0.00 | 112,900.0000 | 40,816,694 | 9999.99% | 0.28% |
| Oct. 18, 2024 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | M | Common Stock | 9750 | $0.00 | 13,902.0000 | 41,443,317 | 234.83% | 0.02% |
| Oct. 18, 2024 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | M | Restricted Stock Units | 9750 | $0.00 | 29,250.0000 | 41,443,317 | 25.00% | 0.02% |
| Oct. 21, 2024 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | S | Common Stock | 2923 | $6.50 | 10,979.0000 | 41,443,317 | 21.03% | 0.01% |
| Feb. 13, 2024 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | A | Restricted Stock Units | 43750 | $0.00 | 43,750.0000 | 19,884,007 | 9999.99% | 0.22% |
| Feb. 13, 2024 | Solid Biosciences Inc. | $SLDB | Brooks Gabriel | Chief Medical Officer | A | Employee Stock Option (Right to Buy) | 87500 | $0.00 | 87,500.0000 | 19,884,007 | 9999.99% | 0.44% |